These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 8310097)
21. N-desmethylclozapine, an insensitive marker of clozapine-induced agranulocytosis and granulocytopenia. Combs MD; Perry PJ; Bever KA Pharmacotherapy; 1997; 17(6):1300-4. PubMed ID: 9399615 [TBL] [Abstract][Full Text] [Related]
22. Notes from a state mental health directors' meeting on clozapine. Salzman C Hosp Community Psychiatry; 1990 Aug; 41(8):838-9, 842. PubMed ID: 2401474 [No Abstract] [Full Text] [Related]
23. Clozapine. Comments by a Sandoz official. Westlin WF Hosp Community Psychiatry; 1990 Aug; 41(8):874-6. PubMed ID: 2119335 [No Abstract] [Full Text] [Related]
26. [Nursing care of granulocytopenia caused by clozapine]. Tu LJ Zhonghua Hu Li Za Zhi; 1993 Oct; 28(10):584-6. PubMed ID: 8111875 [No Abstract] [Full Text] [Related]
27. Clozapine-induced agranulocytosis and colony-stimulating cytokines. Ryabik BM; Nguyen VT; Mann RM; Smith JD; Lippmann SB Gen Hosp Psychiatry; 1993 Jul; 15(4):263-5. PubMed ID: 7688331 [TBL] [Abstract][Full Text] [Related]
28. Clozapine-induced eosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies. Zipris P; Melamed Y; Weizman A; Bleich A Isr J Psychiatry Relat Sci; 2007; 44(1):54-6. PubMed ID: 17665812 [TBL] [Abstract][Full Text] [Related]
29. A Dutch guideline for the use of clozapine. Schulte PF; Cohen D; Bogers JP; van Dijk D; Bakker B Aust N Z J Psychiatry; 2010 Nov; 44(11):1055-6. PubMed ID: 21034191 [No Abstract] [Full Text] [Related]
31. Haematological side effects of clozapine: patient characteristics. Miller PR; Cutten AE N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414 [TBL] [Abstract][Full Text] [Related]
32. Effects of the clozapine national registry system on incidence of deaths related to agranulocytosis. Honigfeld G Psychiatr Serv; 1996 Jan; 47(1):52-6. PubMed ID: 8925346 [TBL] [Abstract][Full Text] [Related]
33. [Leponex: experience of the hospital pharmacist]. Gury C; Dechelette N; Gayral P Encephale; 1995 Jun; 21 Spec No 3():61-5. PubMed ID: 7628345 [TBL] [Abstract][Full Text] [Related]
35. [Clozapine in the treatment of schizophrenia]. Kane JM Encephale; 1991 Jun; 17 Spec No 2():159-63. PubMed ID: 1864262 [No Abstract] [Full Text] [Related]
36. Clozapine: benefits and risks. Fuchs AM Schizophr Bull; 1994; 20(1):23-4. PubMed ID: 8197418 [No Abstract] [Full Text] [Related]
37. Granulocyte colony-stimulating factor treatment of clozapine-induced agranulocytosis. Pasquale D; Newton M; Goss JB; Simor G; Lesieur S Am J Psychiatry; 1996 Nov; 153(11):1503-4. PubMed ID: 8890691 [No Abstract] [Full Text] [Related]
38. Genetic factors in clozapine-induced agranulocytosis. Reznik I; Mester R Isr Med Assoc J; 2000 Nov; 2(11):857-8. PubMed ID: 11344758 [No Abstract] [Full Text] [Related]
39. Late-onset agranulocytosis in a patient with schizophrenia after 17 months of clozapine treatment. Bhanji NH; Margolese HC; Chouinard G; Turnier L J Clin Psychopharmacol; 2003 Oct; 23(5):522-3. PubMed ID: 14520134 [No Abstract] [Full Text] [Related]
40. Clozapine: is another view valid? Meltzer HY Am J Psychiatry; 1995 Jun; 152(6):821-5. PubMed ID: 7755109 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]